GLP-1 (or glucagon-like peptide-1) is a type of hormone produced by the gut that helps manage hunger and blood sugar levels
Semaglutide users already face increased nausea and reduced oral fluid intake due to appetite suppression, creating a compounding dehydration risk
Van Zyl explains: The evidence is suggesting that for some people, like with type 2 diabetes or significant comorbidities, longer-term approaches are advised
Still, there are ways to manage physical discomfort while taking GLP-1 medications and, if and when the time is right for a patient, breast appearance, too
Hes claiming that we shouldnt be seeing any reduction in oxidative stress to almost negligible in less than 72 hours
Moving my body helps tighten up my loose skin